Please enter keyword
OK
Please enter keyword
OK
English
Animal&Cell Models
B-NDG series immunodeficient mice
Product number
General naming
Application area
110586
Immune reconstitution, CDX, transplantation, drug evaluation
110586
Immune reconstitution, CDX, transplantation, drug evaluation
110587
Human immune system reconstitution
110601
Reduce PBMC reconstitution GVHD response and prolong experimental window
110600
Promote human NK cell differentiation
110599
Vaccine study
110596
Promotes human monocyte differentiation
110590
Without irradiation, it reduces the damage caused by irradiation to mice
110604
Maintain progenitor capacity
120612
Promote differentiation of human T cells and NK cells
110603
Evaluation of pharmacodynamic and toxicity of CD47, SIRPA targeted drugs
120609
Promote differentiation of human myeloid cells without irradiation
112869
This product results in a high level of immune system reconstitution after the transplantation of hematopoietic stem cells, especially for DC cells.
112864
Promote differentiation of human monocyte-macrophage
112480
Irradiation is not required to avoid damage to mice caused by irradiation
112479
Promote differentiation of human myeloid cells;Irradiation is not required to avoid damage to mice caused by irradiation
112865
To verify the efficacy of HLA-A2.1 restricted vaccines;Promote the development of human CD8+ T cells
112451
To verify the efficacy of HLA-A11.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112560
To verify the efficacy of HLA-A24.2 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112450
To verify the efficacy of HLA-A3.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112256
No MHC class I molecule expression; Reduce GVHD and prolong the experimental window period; Improve the accuracy of efficacy verification
111982
Used for pharmacological or pharmacokinetic studies of drugs that utilize albumin to extend their half-life
112653
Promote differentiation of human NK cells;No mouse Fc receptor function
112478
Promote differentiation of human NK cells
112482
Promote differentiation of human NK cells
112449
To verify the efficacy of HLA-A2.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112470
Human immune system reconstitution, mainly T cells and B cells;reconstitutionl Human-derived cell or tissue engraftmentl Tumor research;Human disease model studyl Efficacy and toxicity verification for
112469
Human T cell reconstitution;Human-derived cell or tissue engraftment;Tumor researchl Human disease model study;Efficacy and toxicity verification for human targeted drugs
110593
Promote differentiation of human myeloid cells;For mating with other humanized mice that promote myeloid cell differentiation to obtain multi-humanized mice
110598
Hairless, easy to measure tumor
110597
Promote differentiation of human lymphoid cells
110595
No MHC class II molecule expression; Reduce GVHD and prolong the experimental window period;Improve the accuracy of efficacy verification
111882
Promote differentiation of human myeloid cells;Irradiation is not required to avoid damage to mice caused by irradiatio
111895
No MHC class I/II molecule expression;Reduce GVHD and prolong the experimental window period;Improve the accuracy of efficacy verification
111922
PK (NDG background can reduce ADA)
111856
Human immune system reconstitution
110605
Antibody CDC function study